ADMINISTRATION
ADMINISTRATION
批准号:
7303279
负责人:
ANDREW A. RAUBITSCHEK
金额:
$4.76万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-06-30
关键词:
Applications GrantsAttentionAuthorization documentationCD19 geneCertificationCitiesCity of Hope Comprehensive Cancer CenterClinicalClinical ProtocolsClinical ResearchClinical TrialsCoordination and CollaborationData SetDocumentationEvaluationExtramural ActivitiesFutureGrantHuman ResourcesImmunotherapeutic agentLaboratoriesLaboratory ResearchMaintenanceMalignant NeoplasmsMonitorNational Cancer InstituteOccupational activity of managing financesOffice of Administrative ManagementPatientsPersonnel ManagementPreparationPrincipal InvestigatorProceduresProcessProductionProgram Research Project GrantsProtocols documentationPublicationsRadioimmunoconjugateRecordsRegulatory AffairsReportingResearchResearch ActivityResearch InstituteResearch PersonnelResearch SupportScientistStagingSupport of ResearchT-LymphocyteTestingTherapeuticTimeUnited States Food and Drug AdministrationWorkbasedesignexperiencemanufacturing facilitymemberpre-clinicalprogramsprotocol developmenttumor immunology
中文摘要
核心F核心主任:劳比切克,安德鲁首席研究员:劳比切克。安德鲁
产品说明:
F,行政核心,位于贝克曼研究所的癌症部门
免疫治疗学和肿瘤免疫学,负责促进和审查整体活动
的计划。该核心将为行政和财务管理以及所有临床
和实验室研究协调本计划项目补助金。行政支助(管理
人事和财务事项),以便顺利完成工作
在这份赠款中提出。我们的计划项目是一个综合的跨学科计划,其中包括
希望之城综合癌症中心和贝克曼的几个部门和项目
研究院三个项目中科学家提出的临床前和临床研究
而本资助申请中描述的五个核心需要在协调和合作方面做出重大努力
它由Core F支持。行政核心还将安排执行和指导
委员会会议将审查工作进展情况,并组织年度外部咨询
董事会会议。最后,该核心小组将负责提交和监测内部和
外部法规事务材料,以确保遵守和报告要求,
及时提交IND申请。
英文摘要
Core F core Director: Raubitschek, Andrew Principal investigator: Raubitschek. Andrew
DESCRIPTION:
F, the Administrative CORE, is located in the Beckman Research Institute's Division of Cancer
Immunotherapeutics & Tumor Immunology and is responsible for facilitating and reviewing the overall activity
of the program. This core will provide support for administrative and financial management and for all clinical
and laboratory research coordination of this Program Project Grant. Administrative support (management of
personnel and fiscal matters) on an ongoing basis is required for the successful completion of the work
proposed in this grant. Our Program Project is an integrated interdisciplinary program, which incorporates
several divisions, and programs within the City of Hope Comprehensive Cancer Center and Beckman
Research Institute. The preclinical and clinical studies which are proposed by scientists in the three Projects
and the five Cores described in this grant application require a major effort in coordination and collaboration
which is supported by Core F. The Administrative Core will also arrange the Executive and Steering
Committee meetings that will review the progress of the work and organize the annual External Advisory
Board meetings. Lastly, this CORE will be responsible for the submission and monitoring of both internal and
external regulatory affairs materials to insure that compliance and reporting requirements are maintained and
that the IND application is submitted in a timely manner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administration
-
批准号:8566831
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2012
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
-
批准号:8142302
-
项目类别:
-
资助金额:$199.98万
-
财政年份:2010
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
CEA TARGETED IMMUNOTHERAPEUTICS
-
批准号:7303273
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2007
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Constructs for anti-CD20 Directed Therapeutics
-
批准号:6992458
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2004
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Anti-CD30 Radioimmunotherapy of Lymphoma
-
批准号:6991128
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2004
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Humanized Anti-CD20-IL2 for the Treatment of CD20 Positive Lymphomas
-
批准号:8555439
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2004
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Anit-CD25 Radioimmunotherapy for Hodgkin Lymphoma
-
批准号:8555436
-
项目类别:
-
资助金额:$109.81万
-
财政年份:2004
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
CORE--RADIOPHARMACY
-
批准号:6300277
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2000
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
RADIOIMMUNOTHERAPY AND BONE MARROW TRANSPLANTATION IN HEMATOLOGIC MALIGNANCY
-
批准号:6102097
-
项目类别:
-
资助金额:$22.99万
-
财政年份:1999
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
CORE--RADIOPHARMACY
-
批准号:6102346
-
项目类别:
-
资助金额:$15.65万
-
财政年份:1999
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
CORE--RADIOPHARMACY
-
批准号:6269270
-
项目类别:
-
资助金额:$23.57万
-
财政年份:1998
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
-
批准号:7303171
-
项目类别:
-
资助金额:$292.28万
-
财政年份:1998
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
CEA TARGETED IMMUNOTHERAPEUTICS
-
批准号:8555215
-
项目类别:
-
资助金额:$47.16万
-
财政年份:1998
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
-
批准号:8129483
-
项目类别:
-
资助金额:$174.57万
-
财政年份:1998
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
-
批准号:7655398
-
项目类别:
-
资助金额:$300.15万
-
财政年份:1998
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
RADIOIMMUNOTHERAPY AND BONE MARROW TRANSPLANTATION IN HEMATOLOGIC MALIGNANCY
-
批准号:6269142
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1998
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
-
批准号:7483770
-
项目类别:
-
资助金额:$291.62万
-
财政年份:1998
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
-
批准号:7882444
-
项目类别:
-
资助金额:$305.78万
-
财政年份:1998
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
CORE--RADIOPHARMACY
-
批准号:6236867
-
项目类别:
-
资助金额:$24.29万
-
财政年份:1997
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
RADIOIMMUNOTHERAPY AND BONE MARROW TRANSPLANTATION IN HEMATOLOGIC MALIGNANCY
-
批准号:6236633
-
项目类别:
-
资助金额:$21.28万
-
财政年份:1997
-
负责人:ANDREW A. RAUBITSCHEK
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位:
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:82202156
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位: